한글목차

세계 단일 세포 유전체학 및 단백질체학 시장 규모는 2024년 40억 달러에서 예측 기간 동안 17.6%의 연평균 복합 성장률(CAGR)을 기록하며 2029년 말에는 91억 달러에 달할 것으로 예상됩니다.

북미 시장은 2024년 19억 달러에서 예측 기간 동안 17.8%의 연평균 복합 성장률(CAGR)로 성장하여 2029년 말에는 43억 달러에 달할 것으로 예상됩니다. 아시아태평양은 2024년 8억 8,720만 달러에서 18.1%의 연평균 복합 성장률(CAGR)로 2029년 말에는 20억 달러에 이를 것으로 예상됩니다.

세계의 싱글셀 오믹스(Single Cellularomics) 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 법 및 규제 환경, 신기술 및 기술 개발 동향, 시장 규모 추이와 예측, 각종 부문별/지역별 상세 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 주요 요약

• 시장 전망
• 조사 범위
• 시장 요약

제2장 시장 개요

• 개요
• 기술적 배경
• 오믹스 유형
• 기술 인프라와 데이터 통합
• 거시경제 요인 분석
• 진행중인 러시아·우크라이나 전쟁이 싱글셀 유전체학 및 단백질체학 시장에 미치는 영향
• 경제의 불확실성과 연구 자금 삭감
• 운영 비용 증가
• 지정학적 협력 변화
• 러시아와 기술 수출에 대한 제재
• Porter의 Five Forces 분석

제3장 규제 상황

• 규제 개요
• 국가/지역별 시장 규제
• 연방 규제
• CMS 규제
• FDA 규제
• FTC 규제
• 캐나다
• EU
• 영국
• 중국
• 일본
• 호주
• 국제기준과 가이드라인

제4장 시장 역학

• 시장 역학
• 시장 성장 촉진요인
• 시장 성장 억제요인
• 시장 기회

제5장 신기술과 개발

• 싱글셀 유전체학 및 단백질체학 AI
• AI 싱글셀 유전체학 및 단백질체학 시장 기업
• 싱글셀 오믹스와 멀티 오믹스의 진보

제6장 시장 세분화 분석

• 시장 개요
• 세분화 내역
• 세계의 싱글셀 유전체학 및 단백질체학 시장 : 분석 유형별
• 싱글셀 유전체학
• 싱글셀 단백질체학
• 싱글셀 전사체학
• 싱글셀 에피유전체학
• 세계의 싱글셀 유전체학 및 단백질체학 시장 : 용도별
• 종양
• 줄기세포 바이올로지
• 면역
• 기타
• 세계의 싱글셀 유전체학 및 단백질체학 시장 : 최종사용자별
• 학술연구기관
• 바이오의약품 및 바이오테크놀러지 기업
• 임상실험실
• 응용 시장
• 지역 분석
• 싱글셀 유전체학 및 단백질체학 시장 : 지역별
• 북미
• 유럽
• 아시아태평양
• 기타 지역

제7장 경쟁 정보

• 개요
• 주요 기업 순위
• 기업이 채택한 주요 전략
• 협업과 파트너십
• 신제품 발매
• 확장과 투자
• 인수합병(M&A)
• 특허 분석
• 요약

제8장 유전체학 및 단백질체학 시장의 지속가능성 : ESG 관점

• ESG 서론
• 시장에서의 ESG 퍼포먼스
• 유전체학 및 단백질체학 업계에서의 ESG 실천
• 환경 문제
• 사회적 문제
• 규정 준수 문제
• ESG 리스크 평가
• BCC의 결론

제9장 부록

• 조사 방법
• 약어
• 기업 개요
• 10X GENOMICS
• AGILENT TECHNOLOGIES INC.
• BD
• BIO-RAD LABORATORIES INC.
• BIO-TECHNE
• BRUKER
• F. HOFFMANN-LA ROCHE LTD.
• ILLUMINA INC.
• MERCK KGAA
• PROMEGA CORP.
• QIAGEN
• SARTORIUS AG
• STANDARD BIOTOOLS
• TECAN TRADING AG
• THERMO FISHER SCIENTIFIC INC.

영문목차

The global market for single-cell genomics and proteomics is expected to grow from $4.0 billion in 2024 to reach $9.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 17.6% from 2024 through 2029.

The North American market for single-cell genomics and proteomics is expected to grow from $1.9 billion in 2024 to reach $4.3 billion by the end of 2029, at a CAGR of 17.8% from 2024 through 2029.

The Asia-Pacific market for single-cell genomics and proteomics is expected to grow from $887.2 million in 2024 to reach $2.0 billion by the end of 2029, at a CAGR of 18.1% from 2024 through 2029.

Report Scope:

The report highlights the current and future market potential of single-cell genomics and proteomics and a detailed analysis of the market drivers, restraints and opportunities. The report also covers market projections for 2029, including a competitive environment and product analysis. The report provides market estimates and forecasts for single-cell genomics and proteomics based on analysis type, application, end user and region. Based on product type, the market is segmented into single-cell genomics, single-cell epigenomics and single-cell transcriptomics. The market is categorized as academic and research organizations, biopharmaceutical and biotechnology companies, and applied markets and clinical laboratories based on end user. The market is segmented into stem cell biology, oncology, immunology, microbiology and others based on application.

The report includes the company profiles of the key players with detailed information about their business segments, financials, product portfolios and recent developments. By geography, the market has been organized into North America, Europe, Asia-Pacific and the Rest of the World (RoW). The North American region includes countries such as the U.S., Canada and Mexico. Europe includes Germany, the UK, Italy, France, Spain and the rest of Europe; Asia-Pacific includes countries such as China, Japan, India, Australia, South Korea and the rest of Asia-Pacific. The Rest of the World includes South America and the Middle East and Africa. For market estimates, data has been provided for 2021 and 2022 as the historic years, 2023 as the base year, and forecast for 2029.

Report Includes:

• 43 data tables and 59 additional tables
• An overview of the global markets and emerging technologies for single-cell genomics and proteomics
• Analyses of the global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
• Evaluation of and forecast for the overall market for single-cell genomics and proteomics, and quantification of the market potential by analysis type, application, end user and region
• Description of cell isolation technologies, including flow cytometry, laser capture microscopy and micromanipulation, and sample preparation technologies, including microfluidics and whole genome amplification/pre-amplification
• Coverage of NGS, qPCR/PCR, microarrays, mass spectrometry and microfluidics
• Discussion of the major market dynamics and shifts, and the regulations, industry challenges, and macroeconomic factors that will affect the single-cell genomics and proteomics market over the coming years
• Review of the patent filings and research publications for innovations in single-cell genomics and proteomics technology
• A discussion of the industry's ESG challenges and practices
• Identification of the companies that are best positioned to meet this demand because of their proprietary technologies, strategic alliances, or other advantages
• Insight into industry structure, competitive landscape, clinical trials and ongoing research activity
• Profiles of the major players, including 10x Genomics, Thermo Fisher Scientific Inc., Illumina Inc., BD and Merck KGaA

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Overview
• Technology Background
• Types of Omics
• Technological Infrastructure and Data Integration
• Macroeconomic Factors Analysis
• Impact of Ongoing Russia-Ukraine War on the Single-cell Genomics and Proteomics Market
• Economic Uncertainty and Research Funding Cuts
• Increased Operational Costs
• Shift in Geopolitical Collaborations
• Sanctions on Russia and Technology Exports
• Porter's Five Forces Analysis
• Bargaining Power of Buyers
• Bargaining Power of Suppliers
• Potential of New Entrants
• Competition in the Industry
• Threat of Substitutes

Chapter 3 Regulatory Landscape

• Regulatory Overview
• Market Regulations by Country/Region
• Federal Regulation
• CMS Regulation
• FDA Regulation
• FTC Regulation
• Canada
• European Union
• United Kingdom (U.K.)
• China
• Japan
• Australia
• International Standards and Guidelines

Chapter 4 Market Dynamics

• Market Dynamics
• Market Drivers
• Increasing Investment and Funding for Single-cell Genomics and Proteomics Research Activities
• Growing Prevalence of Cancer Generating Demand for Personalized Treatments
• Promising Applications of Single-cell Genomics and Proteomics in the Drug Development Process
• Market Restraints
• High Costs Associated with Single-cell Proteomics
• Technical Challenges
• Market Opportunities
• Technological Advances and Automation in Single-cell Studies
• Collaboration and Partnerships

Chapter 5 Emerging Technologies and Developments

• Artificial Intelligence in Single-cell Genomics and Proteomics
• Companies in the AI Single-cell Genomics and Proteomics Market
• Advances in Single-cell Omics and Multi-omics

Chapter 6 Market Segmentation Analysis

• Market Overview
• Segmentation Breakdown
• Global Single-cell Genomics and Proteomics Market by Analysis Type
• Single-cell Genomics
• Single-cell Proteomics
• Single-cell Transcriptomics
• Single-cell Epigenomics
• Global Single-cell Genomics and Proteomics Market by Application
• Oncology
• Stem Cell Biology
• Immunology
• Other Applications
• Global Single-cell Genomics and Proteomics Market by End User
• Academic and Research Organizations
• Biopharmaceutical and Biotechnology Companies
• Clinical Laboratories
• Applied Markets
• Geographic Breakdown
• Global Single-cell Genomics and Proteomics Market by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 7 Competitive Intelligence

• Overview
• Top Players Ranking
• Key Strategies Adopted by Players
• Collaborations and Partnerships
• New Product Launches
• Expansions and Investments
• Mergers and Acquisitions
• Patent Analysis
• Takeaways

Chapter 8 Sustainability in the Genomics and Proteomics Market: ESG Perspective

• Introduction to ESG
• ESG Performance in the Market
• ESG Practices in the Genomics and Proteomics Industry
• Environmental Performance
• Social Performance
• Governance Performance
• ESG Risk Ratings
• Concluding Remarks from BCC Research

Chapter 9 Appendix

• Methodology
• Abbreviations
• Company Profiles
• 10X GENOMICS
• AGILENT TECHNOLOGIES INC.
• BD
• BIO-RAD LABORATORIES INC.
• BIO-TECHNE
• BRUKER
• F. HOFFMANN-LA ROCHE LTD.
• ILLUMINA INC.
• MERCK KGAA
• PROMEGA CORP.
• QIAGEN
• SARTORIUS AG
• STANDARD BIOTOOLS
• TECAN TRADING AG
• THERMO FISHER SCIENTIFIC INC.